Bavencio 200 mg ( 20 mg/ml) (Avelumab)

DADirect awardda35110211SSS.C. GRAL MEDICAL S.R.L.
Estimated valueRON 22,407
DeadlineExpired23 Feb 2024, 11:42
Competition11 participant
Lots11 lot

Keep momentum on this opportunity

Save it on this device now. Create an account when you are ready to track deadlines, notes, and teamwork.

  • Save and reuse search filters
  • Track opportunities as pursuits
  • Get notified when new notices match
Quick actions

Keep this notice in a shortlist so you can return to it without starting a bid.

Keep notes, monitor deadlines and collaborate with your team. This does not submit a bid or contact the buyer.

Receive alerts

Key information

Identifier
da35110211
Contract type
—
Deadline
23 Feb 2024, 11:42
CPV codes
33652000 - Antineoplastic and immunomodulating agents
Status
Awarded
Notice type
DADirect award
Source
SEAP/SICAP
Estimated value
RON 22,407
Publication date
23 Feb 2024, 11:35

Overview

Bavencio 200 mg ( 20 mg/ml) (Avelumab). Prezenta achizitie tine loc de comanda. Livrare: Gral Medical SRL, Aleea Ana Aslan, nr.15, Pitesti, jud.Arges Plată: op 90zile

Contracting authorities1

SS

CUI 15413404

roBucuresti, Romania
[email protected]

Lots1

Documentation0

Documents have not been synced yet. Last checked 14 Oct 2026, 18:59.

Award criteria0

No procedure-level award criteria recorded.

Participants1

Procured items1